Top Biotechnology companies in United States by Gross Profit Margin

This ranking features the top 471 Biotechnology companies in United States ranked by Gross Profit Margin, averaging a Gross Profit Margin of -4,720.16%, for January 15, 2025.

United States

Biotechnology

#	Name	Gross Profit Margin	Reported Date	Stock Price	Change	Country
1	Avalo Therapeutics, Inc. 1 AVTX	177.80%	Sept. 30, 2024	USD 6.52	-5.10%	United States
2	iBio, Inc. 2 IBIO	114.29%	Sept. 30, 2024	USD 2.73	10.08%	United States
3	Arcturus Therapeutics Holdings Inc. 3 ARCT	104.50%	Sept. 30, 2024	USD 16.59	-4.16%	United States
4	Daxor Corporation 4 DXR	100.01%	June 30, 2024	USD 8.43	2.18%	United States
5	SeaStar Medical Holding Corporation 5 ICU	100.00%	Sept. 30, 2024	USD 1.91	-2.05%	United States
6	Apollomics, Inc. 6 APLM	100.00%	June 30, 2024	USD 10.12	-6.73%	United States
7	VistaGen Therapeutics, Inc. 7 VTGN	100.00%	Sept. 30, 2024	USD 2.84	-3.07%	United States
8	VYNE Therapeutics Inc. 8 VYNE	100.00%	Sept. 30, 2024	USD 2.75	-8.94%	United States
9	INmune Bio, Inc. 9 INMB	100.00%	Sept. 30, 2024	USD 5.96	-8.87%	United States
10	Cyclerion Therapeutics, Inc. 10 CYCN	100.00%	Sept. 30, 2024	USD 2.92	-9.60%	United States
11	Xenetic Biosciences, Inc. 11 XBIO	100.00%	Sept. 30, 2024	USD 4.26	4.41%	United States
12	BeyondSpring Inc. 12 BYSI	100.00%	June 30, 2024	USD 1.65	0.61%	United States
13	LungLife AI, Inc. 13 LLAI.L	100.00%	Dec. 31, 2023	USD 0.09	0.09%	United States
14	Perspective Therapeutics, Inc. 14 CATX	100.00%	Sept. 30, 2024	USD 3.20	-5.88%	United States
15	MediciNova, Inc. 15 MNOV	99.98%	Sept. 30, 2023	USD 1.91	-4.02%	United States
16	Lisata Therapeutics, Inc. 16 LSTA	99.84%	Sept. 30, 2023	USD 3.64	-0.82%	United States
17	Verastem, Inc. 17 VSTM	99.83%	Sept. 30, 2024	USD 5.04	-5.62%	United States
18	Coya Therapeutics, Inc. 18 COYA	99.71%	Sept. 30, 2024	USD 5.65	-5.36%	United States
19	Ironwood Pharmaceuticals, Inc. 19 IRWD	99.60%	Sept. 30, 2024	USD 3.65	-3.18%	United States
20	Assembly Biosciences, Inc. 20 ASMB	99.48%	Sept. 30, 2024	USD 14.74	-1.01%	United States
21	Protagonist Therapeutics, Inc. 21 PTGX	99.21%	Sept. 30, 2024	USD 36.67	-1.26%	United States
22	XOMA Corporation 22 XOMA	98.94%	Sept. 30, 2024	USD 26.71	5.16%	United States
23	CytomX Therapeutics, Inc. 23 CTMX	98.88%	Sept. 30, 2024	USD 0.84	-5.23%	United States
24	Lipella Pharmaceuticals Inc. 24 LIPO	98.75%	Sept. 30, 2024	USD 3.05	0.33%	United States
25	iTeos Therapeutics, Inc. 25 ITOS	98.69%	Sept. 30, 2023	USD 7.66	-1.80%	United States
26	Adial Pharmaceuticals, Inc. 26 ADIL	98.69%	Sept. 30, 2024	USD 1.02	0.99%	United States
27	Cartesian Therapeutics, Inc. 27 RNAC	98.64%	Sept. 30, 2024	USD 18.02	-1.69%	United States
28	Akero Therapeutics, Inc. 28 AKRO	98.59%	Sept. 30, 2024	USD 21.87	-3.36%	United States
29	Prime Medicine, Inc. 29 PRME	98.47%	Sept. 30, 2024	USD 2.70	-2.53%	United States
30	Corcept Therapeutics Incorporated 30 CORT	98.44%	Sept. 30, 2024	USD 51.66	1.18%	United States
31	Entrada Therapeutics, Inc. 31 TRDA	98.39%	Sept. 30, 2024	USD 12.49	-6.58%	United States
32	BridgeBio Pharma, Inc. 32 BBIO	98.31%	Sept. 30, 2024	USD 35.60	5.54%	United States
33	Aprea Therapeutics, Inc. 33 APRE	98.28%	Sept. 30, 2024	USD 3.62	5.85%	United States
34	Sagimet Biosciences Inc. 34 SGMT	98.25%	June 30, 2024	USD 4.16	-9.17%	United States
35	Arcellx, Inc. 35 ACLX	98.21%	Sept. 30, 2024	USD 64.65	-4.02%	United States
36	Enanta Pharmaceuticals, Inc. 36 ENTA	98.13%	Sept. 30, 2024	USD 4.84	-3.78%	United States
37	BioCryst Pharmaceuticals, Inc. 37 BCRX	97.91%	Sept. 30, 2024	USD 7.23	-8.83%	United States
38	Zentalis Pharmaceuticals, Inc. 38 ZNTL	97.68%	Sept. 30, 2024	USD 2.65	3.52%	United States
39	AVITA Medical, Inc. 39 RCEL	97.62%	Sept. 30, 2023	USD 8.89	0.79%	United States
40	Daré Bioscience, Inc. 40 DARE	97.57%	Sept. 30, 2024	USD 3.34	0.30%	United States
41	Day One Biopharmaceuticals, Inc. 41 DAWN	97.37%	Sept. 30, 2024	USD 11.16	-3.46%	United States
42	Ionis Pharmaceuticals, Inc. 42 IONS	97.30%	Sept. 30, 2024	USD 32.69	-6.44%	United States
43	Dominari Holdings Inc. 43 DOMH	97.16%	Sept. 30, 2024	USD 1.03	-0.96%	United States
44	Geron Corporation 44 GERN	96.53%	Sept. 30, 2024	USD 2.94	-1.34%	United States
45	Exelixis, Inc. 45 EXEL	96.25%	Sept. 27, 2024	USD 35.65	0.99%	United States
46	Arcus Biosciences, Inc. 46 RCUS	96.20%	Sept. 30, 2024	USD 13.82	-0.79%	United States
47	HOOKIPA Pharma Inc. 47 HOOK	95.85%	Sept. 30, 2024	USD 1.86	4.49%	United States
48	AnaptysBio, Inc. 48 ANAB	95.80%	Sept. 30, 2024	USD 14.91	1.98%	United States
49	Capricor Therapeutics, Inc. 49 CAPR	95.71%	Sept. 30, 2024	USD 12.59	-1.02%	United States
50	Tango Therapeutics, Inc. 50 TNGX	95.68%	Sept. 30, 2024	USD 2.62	-8.39%	United States

1 2 3 4 … 10

Frequently Asked Questions

Which Biotechnology company in United States has the highest Gross Profit Margin ?

The Biotechnology company in United States with the highest Gross Profit Margin is Avalo Therapeutics, Inc. (NasdaqCM: AVTX) at 177.80%.
Which Biotechnology company in United States has the lowest Gross Profit Margin ?

The Biotechnology company in United States with the lowest Gross Profit Margin is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at -1,970,400.00%.

What are the top 10 Biotechnology companies in United States by Gross Profit Margin ?

The top 10 Biotechnology companies in United States by Gross Profit Margin are Avalo Therapeutics, Inc., iBio, Inc., Arcturus Therapeutics Holdings Inc., Daxor Corporation, SeaStar Medical Holding Corporation, Apollomics, Inc., VistaGen Therapeutics, Inc., VYNE Therapeutics Inc., INmune Bio, Inc. and Cyclerion Therapeutics, Inc..
What are the bottom 10 Biotechnology companies in United States by Gross Profit Margin ?

The bottom 10 Biotechnology companies in United States by Gross Profit Margin are Inhibikase Therapeutics, Inc., Allogene Therapeutics, Inc., Checkpoint Therapeutics, Inc., Revolution Medicines, Inc., Chimerix, Inc., PureTech Health plc, Sharps Technology, Inc., Alaunos Therapeutics, Inc., Altimmune, Inc. and Kyverna Therapeutics, Inc..